Clinical Trial Update: SHR2554 Combined With Endocrine Therapy in Advanced Breast Cancer [Phase 2]

View source ↗

Summary

A Phase 2 clinical trial is evaluating SHR2554 in combination with endocrine therapy for advanced breast cancer, which is currently not yet recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Breast Cancer

Drugs mentioned

• SHR2554

Snippet

Sponsor: Henan Cancer Hospital | Conditions: Advanced Breast Cancer | Phase 2 | Status: NOT_YET_RECRUITING